Low Threshold Buprenorphine Induction at Harm Reduction Centers 2027
Low Threshold Buprenorphine Induction at Harm Reduction Centers 2027 supports harm reduction centers in providing buprenorphine induction to expand opioid use disorder treatment access and reduce overdose deaths.
Funder: New Jersey Department of Health
Due Dates: September 29, 2026 (Application deadline)
Funding Amounts: $2,822,533 estimated program funding; award period September 30, 2026–September 29, 2027
Summary: Supports buprenorphine induction at harm reduction centers to expand opioid use disorder treatment access and reduce overdose-related deaths.
Key Information: Only the six agencies currently funded for harm reduction centers under DHST26BUP may apply.
Description
The New Jersey Department of Health funds low-threshold buprenorphine induction at harm reduction centers as part of the State Opioid Response. The program aims to expand access to medication-assisted treatment for opioid use disorder and reduce unmet treatment need.
By placing treatment access within harm reduction centers, the program also seeks to reduce opioid overdose-related deaths through prevention, treatment, and recovery activities. The Department’s Division of Syndemic and Substance Use Services lists the opportunity in its grant directory.
